PANTHER BIOTECHNOLOGY
Panther Biotechnology, Inc. is an entity focused on the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and antiviral disorders. The Company is currently developing three clinical candidates, TRF-DOX, which is a combination of transferrin glycoproteins with Doxorubicin for targeted delivery to tumors with the reduction of serious side effects, Numonafide, which is a derivative of the widely studied anticancer drug Amonafide optimized to eliminate ... toxic metabolites and reduce side effects, and TDZD-8, a kinase inhibitor targeting cancer stem cells. Panther is continuing its acquisition strategy focusing on identifying undervalued companies and clinical assets, including those programs that have missed clinical endpoints, and bring scientific and medical personnel capable of running the trials and extracting value from the assets.
PANTHER BIOTECHNOLOGY
Industry:
Biotechnology
Founded:
2011-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.pantherbiotechnology.com
Total Employee:
1+
Status:
Active
Contact:
202-462-9582
Email Addresses:
[email protected]
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-07-01 | Alchemia | Alchemia acquired by Panther Biotechnology | N/A |
Official Site Inspections
http://www.pantherbiotechnology.com
- Host name: 192.64.119.111
- IP address: 192.64.119.111
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Panther Biotechnology"
Panther Biotechnology - Crunchbase Company Profile …
Panther Biotechnology, Inc. is an entity focused on the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and antiviral disorders. The Company is currently developing …See details»
Panther Biotechnology - PitchBook
Panther Biotechnology General Information Description. Developer of small molecule therapeutics designed to treat neoplastic, autoimmune and antiviral disorders. The company's small …See details»
Panther Biotechnology - Drug pipelines, Patents, Clinical trials
Explore Panther Biotechnology with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
Panther Biotechnology - Funding, Financials, Valuation & Investors
Jul 1, 2015 Organization. Panther Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Edit Acquisitions Section. Number of …See details»
Panther Biotechnology, Inc. Announces the Appointment of Two …
Aug 26, 2014 Panther Biotechnology, Inc. announced today the appointments of Mr. David Barshis and Mr. James Sapirstein to the company's Board of Directors. In addition the Panther …See details»
Panther Biotechnology, Inc. Announces $1.215 Million Financing …
Aug 25, 2015 Panther Biotechnology, Inc. is an entity focused on the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and …See details»
NewMediaWire | Panther Biotechnology Announces the Closing of …
Nov 15, 2016 New Division Will Provide Immediate Growing Revenue to PantherLA JOLLA, CA and HOUSTON, TX - (NewMediaWire) - November 15, 2016 - Panther Biotechnology, Inc. …See details»
Panther Biotechnology - Company Profile - Tracxn
Nov 18, 2024 Panther Biotechnology - Therapeutics for cancer. Raised a total funding of $1.21M over 1 round from 1 investor. Panther Biotechnology has 2866 competitors.See details»
Panther Biotechnology Announces the Closing of the Merger with …
Nov 15, 2016 Panther Biotechnology, Inc. , or Panther, is pleased to announce today that it has executed a share exchange agreement to merge with Brown Technical Media Corp., or Brown, …See details»
Panther Biotechnology Inc. - BioCentury Company Profiles - BCIQ
Aug 24, 2015 Panther Biotechnology Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Panther Biotechnology - Manufacturing Chemist
Panther Biotechnology announces acquisition of Alchemia Oncology. The acquisition further strengthens Panther's drug development and platform technology portfolio Drug Delivery. …See details»
Panther Biotechnology announces acquisition of Alchemia Oncology
Jul 3, 2015 Panther Biotechnology, a biotechnology company specialising in the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and …See details»
Panther Biotechnology Announces the Acquisition of Alchemia …
Jul 1, 2015 Panther Biotechnology, Inc. is an entity focused on the acquisition and development of enhanced therapeutics for the treatment of neoplastic, autoimmune and antiviral disorders. …See details»
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpaceSee details»
Panther Biotechnology - Tech Stack, Apps, Patents & Trademarks
Organization. Panther Biotechnology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 11. About. …See details»
Panther Biotechnology Announces The Initiation Of Formal
Jul 15, 2016 LA JOLLA, CA--(Marketwired - July 14, 2016) - Panther Biotechnology, Inc. (OTC PINK: PBYA) (Panther), a biotechnology company specializing in the development of …See details»
Panther Biotechnology Announces The Closing Of The Merger
Nov 15, 2016 LA JOLLA, CA and HOUSTON, TX--(Marketwired - November 15, 2016) - Panther Biotechnology, Inc. (OTC PINK: PBYA), or Panther, is pleased to announce today that it has …See details»
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance …
Aug 22, 2022 PanTher Therapeutics received a $14.2 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT).See details»
PanTher Therapeutics Awarded $14.2M from CPRIT to Advance
Aug 22, 2022 WATERTOWN, Mass.--(BUSINESS WIRE)-- PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage oncology company developing next-generation targeted …See details»
PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting …
May 24, 2022 WATERTOWN, Mass.--(BUSINESS WIRE)--PanTher Therapeutics (PanTher), a clinical-stage oncology company developing next-generation targeted therapies for solid …See details»